CBM Financial Facts

Net sales: 93.43M
Research and development expenses: 3.48M
See Full Income Statement

Total stockholders' equity: 335.07M
Trade receivables, net: 47.32M
See Full Balance Sheet

Cambrex Corp. (CBM) Earnings

  |   Expand Research on CBM
Next EPS Date 8/1/16 *Est. EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +9.9% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +6.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/28/16 Q116 N/A$0.34 N/A N/A$83.61M N/A N/A N/A
2/9/16 Q415 $0.54$0.83 -$0.29$156.9M$152.94M N/A Details
11/3/15 Q315 $0.40$0.38 +$0.02$92.98M$101.09M Details
7/30/15 Q215 $0.63$0.44 +$0.19$106.4M$110.03M Details
5/1/15 Q115 $0.29$0.23 +$0.06$78.2M$76.01M Details
2/6/15 Q414 $0.64$0.50 +$0.14$128.8M$117.9M Details
10/30/14 Q314 $0.28$0.26 +$0.02$81.1M$94.25M = Details
8/1/14 Q214 $0.35$0.28 +$0.07$98M$92.7M = Details